BACKGROUND Pharmaceutical companies in Africa need to invest in both facilities and quality management systems to achieve good manufacturing practice (GMP) compliance. Compliance to international GMP standards is important to the attainment of World Health Organization (WHO) prequalification. However, most of the local pharmaceutical manufacturing companies may be deterred from investing in qua...

This paper analyzes the changing R&D process at Japanese pharmaceutical companies, based on a questionnaire survey as well as structured interviews at large Japanese pharmaceutical companies. Japanese pharmaceutical companies have recently engaged in active R&D collaborations with other firms as well as universities. This paper identifies the factors underlying this trend, finding that all thre...

Unlike the health of our bodies, the health of our minds is often neglected. In 2007, The Lancet’s Series on Global Mental Health sought to draw attention to the worldwide burden of mental illness. Data published by Michael Phillips and colleagues in this issue indicate that mental health disorders might aff ect far more people than previously estimated. Their study took on the challeng ing tas...

Product liability is one of the fastest growing and most economically significant applications of tort law. Product liability actions against pharmaceutical companies are among the most widely publicized classes of suits in the United States and Europe, prompting pharmaceutical companies to lobby vigorously for tort reform. (Nace et al., 1997). The liability burden on pharmaceutical companies h...

The Data mining is gradually becoming an integral and essential part of health and pharmaceutical industry. Data mining techniques are being regularly used to assess efficacy of treatment, management of ailments, and also in various stages of drug discovery and process research. Off late, data mining has become a boon in health insurance sector to minimize frauds and abuse. A good number of hea...

Funding combination is the most important issue for the companies while they know the amount of required capital. Companies should be careful regarding the appliance of financial providing methods compatible with the investment strategy of company and profitability. This study seeks to examine the relationship between the capital structure and the profitability of pharmaceutical companies in Ir...

stock return is usually considered to be affected by firm’s financial ratios as well as economic variables. fundamental method assume that stock returns is not solely related to the stock market. most result come from the company condition , industry situation and whole economy. in this paper, this relationship between stock return and fundamentals is studied using the data for 22 pharmaceutica...

Three recent systematic reviews have shown that pharmaceutical industry funding of clinical trials is strongly associated with pro-industry results. This article builds on those analyses, situating funding's effects in the context of the ghost-management of research and publication by pharmaceutical companies, and the creation of social ties between those companies and researchers. There are mu...

Goods, information, financial and technology resources flow through supply chains, and pharmaceutical companies face a very specific challenge: ethical drugs must be prescribed by physicians to be bought or used by final consumers. That gives a unique design to their supply chains. This paper aims to understand how the supply chains of pharmaceutical companies are configured. It especially expl...